Skip to Content
Merck
HomeAdvanced Gene EditingX-tremeGENE™ Transfection Reagents

X-tremeGENE™ Transfection Reagents

Understanding the Mechanisms of Transfection

Learn how optimizations like reagent selection, DNA/RNA : transfection reagent ratio, and protocol/method are critical determinants of transfection efficiencies.

X-tremeGENETM HP, X-tremeGENETM 9, and X-tremeGENETM 360 transfection reagents

The ability to successfully transfect a cell varies significantly depending on the cell type, protocol, and the composition of the transfection reagent. X-tremeGENE™ transfection reagents are designed to efficiently transfect common and difficult-to-transfect cells with a variety of molecules, including DNA, small RNAs, and CRISPR/Cas9 components.

X-tremeGENE™ 360 Transfection Reagent is a high-performing, versatile and reliable solution for delivery of siRNA/miRNA, plasmid DNA, and CRISPR/Cas9 materials into  hard-to-transfect and common cell types. For more information visit sigmaaldrich.com/xtg360ro.

Section Overview

 X-tremeGENE™ HP DNA Transfection Reagent  X-tremeGENE™ 9 DNA Transfection Reagent  X-tremeGENE™ 360 Transfection Reagent  
Transfection of DNA✓ ✓ ✓✓ ✓ ✓✓ ✓ ✓
Transfection of siRNA/miRNA and CRISPR/Cas9 componentsNRNR✓ ✓ ✓
Efficiency with standard cell lines (e.g., COS-7, HEK-293, HeLa, NIH 3T3, and CHO-K1)✓ ✓ ✓✓ ✓ ✓✓ ✓ ✓
Efficiency with "difficult-to-transfect" cells (e.g., HT 29, HCT 116, and K-562 cells)✓ ✓ ✓✓ ✓✓ ✓ ✓
Transfection of primary cells✓ ✓NR✓ ✓ ✓
Gentleness of the reagent✓ ✓✓ ✓ ✓✓ ✓ ✓
Ease of use (minimal optimization)✓ ✓ ✓✓ ✓ ✓✓ ✓ ✓
Cytotoxicity after transfectionVery lowLowVery low
NR: Not Recommended
Focus ApplicationX-tremeGENE™ HP DNA Transfection ReagentX-tremeGENE™ 9 DNA Transfection ReagentX-tremeGENE™ 360 Transfection ReagentX-tremeGENE™ siRNA Transfection Reagent
Functional studies of cellular processes✓ ✓ ✓✓ ✓ ✓✓ ✓ ✓✓ ✓ ✓
Quantitative protein expression✓ ✓ ✓✓ ✓✓ ✓ ✓
Gene knockdown studies using siRNA

✓ ✓ ✓✓ ✓ ✓
X-tremeGENE™ HP Reagent efficiently transfects human primary fibroblasts

Figure 1.X-tremeGENE™ HP Reagent efficiently transfects human primary fibroblasts.

Primary fibroblasts were isolated from human foreskin and transfected with 4 μL X-tremeGENE HP Reagent and 1 μg of GFP-encoding plasmid DNA in a 6-well cell culture plate. GFP expression was visualized 48 hours after transfection. The left panel shows GFP fluorescence, and the right panel shows the corresponding brightfield image.

 X-tremeGENE™ HP and 9 Reagents outperform the competitor reagent in human mesenchymal stem cells

Figure 2.X-tremeGENE™ HP and X-tremeGENE™ 9 Reagents outperform the competitor reagent in human mesenchymal stem cells.

Human mesenchymal stem cells were isolated from bone marrow aspirate of four different donors. Cells were transfected using X-tremeGENE HP Reagent (XHP), X-tremeGENE 9 Reagent (X9), and a competitor reagent (LTX), using the indicated ratios (μL reagent : μg GFP-encoding plasmid DNA. Ratio 2:1 was not tested using X-tremeGENE 9 Reagent). Untransfected cells served as control (neg). FACS analysis was performed 48 hours after transfection.

X-tremeGENE™ HP DNA Transfection Reagent outperforms competitor reagents in difficult-to-transfect cell types.

Figure 3.X-tremeGENE™ HP DNA Transfection Reagent outperforms competitor reagents in difficult-to-transfect cell types.

X-tremeGENETM 360 outperforms Lipofectamine® reagents in A549 cells.

Figure 4.X-tremeGENETM 360 outperforms Lipofectamine reagents tested in A549 cells. A549 cells were transfected with luciferase encoding plasmid DNA using either X-tremeGENETM 360, Lipofectamine® 2000 (Thermo Fisher Scientific) or Lipofectamine® 3000 (Thermo Fisher Scientific) for 24 hours at indicated reagent-to-DNA ratios. Transfection was measured by luciferase activity using a conventional assay. Cytotoxicity was assessed by quantifying the LDH release from the cytosol of damaged cells compared to cells alone. Higher transgene expression and lower cytotoxicity was observed in cells transfected with X-tremeGENETM 360 at optimal ratios compared to cells transfected with Lipofectamine® 2000 or Lipofectamine® 3000.

Cells were transfected using X-tremeGENE HP Reagent (XHP), and competitor reagents (LTX and L2K), at the indicated ratios (μL reagent : μg GFP-encoding plasmid DNA). Transfection efficiency was visualized using GFP fluorescence microscopy.

Cell-Type Specific Product Recommendations

Established Cell LinesX-tremeGENE™ HP DNA Transfection ReagentX-tremeGENE™ 9 DNA Transfection ReagentX-tremeGENE™ 360 Transfection Reagent
CHO-K1✓ ✓✓ ✓ ✓✓ ✓ ✓
COS-7✓ ✓✓ ✓✓ ✓ ✓
NIH-3T3✓ ✓✓ ✓ ✓
HeLa✓ ✓✓ ✓ ✓✓ ✓ ✓
HEK-293✓ ✓ ✓✓ ✓✓ ✓ ✓
Hep-G2✓ ✓✓ ✓ ✓
HT1080✓ ✓✓ ✓ ✓✓ ✓
HT29NR✓ ✓
PC-3✓ ✓✓ ✓✓ ✓ ✓
K-562✓ ✓ ✓NR✓ ✓ ✓
U-2 OSNR
MCF-7✓ ✓ ✓✓ ✓ ✓
RAWNR✓ ✓
HCT 116✓ ✓ ✓✓ ✓✓ ✓ ✓
JurkatNR
PC-12✓ ✓✓ ✓✓ ✓
Primary Cells   
Human primary fibroblasts✓ ✓NR✓ ✓
MEF✓ ✓NR✓ ✓
Stem Cells   
Human mesenchymal stem cells✓ ✓NR✓ ✓
Mouse embryonic stem cells (E14TG2a)✓ ✓✓ ✓✓ ✓
Insect Cell Lines   
High Five✓ ✓NR✓ ✓
SF9✓ ✓NR✓ ✓
NR: Not Recommended

Note: The above data was produced using either a GFP-encoding pcDNA3.1 plasmid or a luciferase-encoding pCI plasmid, both with the cytomegalovirus (CMV) promoter. These recommendations are guidelines based on experimental findings. The optimal reagent:DNA ratio must be determined empirically.

 

Application Table

Focus ApplicationsRecommended ProductAdvantages
  • Cancer research
    Transfection of common cancer research
    cell lines for functional cellular analysis, including
    gene regulation and protein interaction studies
    and pathway analysis.

  • Target evaluation
    Transfection of common cell lines for target
    evaluation.
  • Low cytotoxicity
  • Minimal reagent-induced off-target effects
  • Simple method
  • Broad applicability across cell types
  • High transfection efficiency at low cell density
  • Active in up to 100% serum
  • Difficult-to-transfect and primary cells
    Transfection of primary cells and "hard-to-transfect"
    cell lines for functional cellular analysis.

  • Protein expression
    Transfection for analytical or quantitative
    protein expression.
  • High levels of protein expression
  • Simple method
  • Rapid protocol
  • High transfection efficiency
  • Active in serum-containing media
  • Synthetic; free of human- or animal-derived components
  • Gene knockdown using siRNA transfection
  • Low cytotoxicity
  • High knockdown efficiency
  • Broad applicability across cell lines
  • Active in serum-containing media
X-tremeGENE™ is a trademark of Roche. For life science research only. Not for use in diagnostic procedures.
Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?